1	CD56+	_	JJ	_	_	6	NMOD	_	_
2	putative	_	JJ	_	_	4	NMOD	_	_
3	natural	_	JJ	_	_	4	NMOD	_	_
4	killer	_	NN	_	_	6	NMOD	_	_
5	cell	_	NN	_	_	6	NMOD	_	_
6	lymphomas	_	NNS	_	_	0	ROOT	_	_
7	:	_	:	_	_	6	P	_	_
8	production	_	NN	_	_	6	APPO	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	cytolytic	_	JJ	_	_	11	NMOD	_	_
11	effectors	_	NNS	_	_	9	PMOD	_	_
12	and	_	CC	_	_	8	COORD	_	_
13	related	_	JJ	_	_	14	NMOD	_	_
14	proteins	_	NNS	_	_	12	CONJ	_	_
15	mediating	_	VBG	_	_	14	APPO	_	_
16	tumor	_	NN	_	_	18	NMOD	_	_
17	cell	_	NN	_	_	18	NMOD	_	_
18	apoptosis	_	NN	_	_	15	VMOD	_	_
19	?	_	.	_	_	6	P	_	_
		
1	Apoptosis	_	NN	_	_	2	VMOD	_	_
2	is	_	VBZ	_	_	0	ROOT	_	_
3	a	_	DT	_	_	5	NMOD	_	_
4	regulated	_	VBN	_	_	5	NMOD	_	_
5	form	_	NN	_	_	2	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	cell	_	NN	_	_	8	NMOD	_	_
8	death	_	NN	_	_	6	PMOD	_	_
9	that	_	WDT	_	_	10	VMOD	_	_
10	may	_	MD	_	_	5	NMOD	_	_
11	be	_	VB	_	_	10	VC	_	_
12	triggered	_	VBN	_	_	11	VC	_	_
13	by	_	IN	_	_	12	VMOD	_	_
14	natural	_	JJ	_	_	15	NMOD	_	_
15	killer	_	NN	_	_	13	PMOD	_	_
16	(	_	(	_	_	17	P	_	_
17	NK	_	NN	_	_	15	PRN	_	_
18	)	_	)	_	_	17	P	_	_
19	or	_	CC	_	_	15	COORD	_	_
20	cytotoxic	_	JJ	_	_	22	NMOD	_	_
21	T	_	NN	_	_	22	NMOD	_	_
22	cells	_	NNS	_	_	19	CONJ	_	_
23	,	_	,	_	_	22	P	_	_
24	which	_	WDT	_	_	25	VMOD	_	_
25	effect	_	VB	_	_	22	NMOD	_	_
26	target	_	NN	_	_	28	NMOD	_	_
27	cell	_	NN	_	_	28	NMOD	_	_
28	lysis	_	NN	_	_	25	VMOD	_	_
29	by	_	IN	_	_	25	VMOD	_	_
30	cytolytic	_	JJ	_	_	31	NMOD	_	_
31	effector	_	NN	_	_	29	PMOD	_	_
32	and	_	CC	_	_	31	COORD	_	_
33	related	_	JJ	_	_	34	NMOD	_	_
34	proteins	_	NNS	_	_	32	CONJ	_	_
35	through	_	IN	_	_	25	VMOD	_	_
36	complex	_	JJ	_	_	38	NMOD	_	_
37	intracellular	_	JJ	_	_	38	NMOD	_	_
38	signals	_	NNS	_	_	35	PMOD	_	_
39	.	_	.	_	_	2	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	study	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	aimed	_	VBN	_	_	3	VC	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	investigate	_	VB	_	_	5	IM	_	_
7	whether	_	IN	_	_	6	VMOD	_	_
8	there	_	EX	_	_	9	VMOD	_	_
9	is	_	VBZ	_	_	7	SUB	_	_
10	selective	_	JJ	_	_	11	NMOD	_	_
11	expression	_	NN	_	_	9	VMOD	_	_
12	of	_	IN	_	_	11	NMOD	_	_
13	these	_	DT	_	_	15	NMOD	_	_
14	cytolytic	_	JJ	_	_	15	NMOD	_	_
15	markers	_	NNS	_	_	12	PMOD	_	_
16	in	_	IN	_	_	11	NMOD	_	_
17	the	_	DT	_	_	20	NMOD	_	_
18	putative	_	JJ	_	_	20	NMOD	_	_
19	NK-cell	_	NN	_	_	20	NMOD	_	_
20	lymphomas	_	NNS	_	_	16	PMOD	_	_
21	and	_	CC	_	_	7	COORD	_	_
22	whether	_	IN	_	_	21	CONJ	_	_
23	there	_	EX	_	_	24	VMOD	_	_
24	is	_	VBZ	_	_	22	SUB	_	_
25	correlation	_	NN	_	_	24	VMOD	_	_
26	with	_	IN	_	_	25	NMOD	_	_
27	zonal	_	JJ	_	_	30	NMOD	_	_
28	tumor	_	NN	_	_	30	NMOD	_	_
29	cell	_	NN	_	_	30	NMOD	_	_
30	death	_	NN	_	_	26	PMOD	_	_
31	in	_	IN	_	_	30	NMOD	_	_
32	these	_	DT	_	_	33	NMOD	_	_
33	tumors	_	NNS	_	_	31	PMOD	_	_
34	.	_	.	_	_	3	P	_	_
		
1	Expression	_	NN	_	_	17	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	5	NMOD	_	_
4	cytolytic	_	JJ	_	_	5	NMOD	_	_
5	effectors	_	NNS	_	_	2	PMOD	_	_
6	perforin	_	NN	_	_	5	NMOD	_	_
7	,	_	,	_	_	6	P	_	_
8	granzyme	_	NN	_	_	9	NMOD	_	_
9	B9	_	NN	_	_	6	COORD	_	_
10	,	_	,	_	_	9	P	_	_
11	and	_	CC	_	_	9	COORD	_	_
12	the	_	DT	_	_	16	NMOD	_	_
13	granule	_	NN	_	_	16	NMOD	_	_
14	membrane	_	NN	_	_	16	NMOD	_	_
15	protein	_	NN	_	_	16	NMOD	_	_
16	TIA1	_	NN	_	_	11	CONJ	_	_
17	were	_	VBD	_	_	0	ROOT	_	_
18	examined	_	VBN	_	_	17	VC	_	_
19	in	_	IN	_	_	18	VMOD	_	_
20	24	_	CD	_	_	23	NMOD	_	_
21	putative	_	JJ	_	_	23	NMOD	_	_
22	NK-cell	_	NN	_	_	23	NMOD	_	_
23	lymphomas	_	NNS	_	_	19	PMOD	_	_
24	,	_	,	_	_	23	P	_	_
25	18	_	CD	_	_	28	NMOD	_	_
26	postthymic	_	JJ	_	_	28	NMOD	_	_
27	T-cell	_	NN	_	_	28	NMOD	_	_
28	lymphomas	_	NNS	_	_	23	COORD	_	_
29	(	_	(	_	_	33	P	_	_
30	one	_	CD	_	_	33	NMOD	_	_
31	case	_	NN	_	_	33	NMOD	_	_
32	CD8+	_	JJ	_	_	33	NMOD	_	_
33	CD56+	_	JJ	_	_	28	PRN	_	_
34	and	_	CC	_	_	33	COORD	_	_
35	three	_	CD	_	_	39	NMOD	_	_
36	anaplastic	_	JJ	_	_	39	NMOD	_	_
37	large	_	JJ	_	_	39	NMOD	_	_
38	cell	_	NN	_	_	39	NMOD	_	_
39	lymphomas	_	NNS	_	_	34	CONJ	_	_
40	(	_	(	_	_	41	P	_	_
41	ALCL	_	NN	_	_	33	PRN	_	_
42	)	_	)	_	_	41	P	_	_
43	,	_	,	_	_	28	P	_	_
44	three	_	CD	_	_	46	NMOD	_	_
45	T-lymphoblastic	_	JJ	_	_	46	NMOD	_	_
46	lymphomas	_	NNS	_	_	28	COORD	_	_
47	,	_	,	_	_	46	P	_	_
48	and	_	CC	_	_	46	COORD	_	_
49	20	_	CD	_	_	51	NMOD	_	_
50	B-cell	_	NN	_	_	51	NMOD	_	_
51	lymphomas	_	NNS	_	_	48	CONJ	_	_
52	.	_	.	_	_	17	P	_	_
		
1	Nineteen	_	CD	_	_	8	NMOD	_	_
2	(	_	(	_	_	4	P	_	_
3	79	_	CD	_	_	4	NMOD	_	_
4	%	_	NN	_	_	8	PRN	_	_
5	)	_	)	_	_	4	P	_	_
6	putative	_	JJ	_	_	8	NMOD	_	_
7	NK-cell	_	NN	_	_	8	NMOD	_	_
8	lymphomas	_	NNS	_	_	9	VMOD	_	_
9	expressed	_	VBD	_	_	0	ROOT	_	_
10	perforin	_	NN	_	_	9	VMOD	_	_
11	,	_	,	_	_	9	P	_	_
12	and	_	CC	_	_	9	COORD	_	_
13	all	_	DT	_	_	15	NMOD	_	_
14	24	_	CD	_	_	15	NMOD	_	_
15	cases	_	NNS	_	_	16	VMOD	_	_
16	expressed	_	VBD	_	_	12	CONJ	_	_
17	granzyme	_	NN	_	_	18	NMOD	_	_
18	B9	_	NN	_	_	16	VMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	TIA1	_	NN	_	_	19	CONJ	_	_
21	.	_	.	_	_	9	P	_	_
		
1	The	_	DT	_	_	7	NMOD	_	_
2	only	_	RB	_	_	3	AMOD	_	_
3	CD8+	_	JJ	_	_	4	AMOD	_	_
4	CD56+	_	JJ	_	_	7	NMOD	_	_
5	postthymic	_	NN	_	_	7	NMOD	_	_
6	T-cell	_	NN	_	_	7	NMOD	_	_
7	lymphoma	_	NN	_	_	9	VMOD	_	_
8	also	_	RB	_	_	9	VMOD	_	_
9	expressed	_	VBD	_	_	0	ROOT	_	_
10	all	_	DT	_	_	13	NMOD	_	_
11	three	_	CD	_	_	13	NMOD	_	_
12	cytolytic	_	JJ	_	_	13	NMOD	_	_
13	markers	_	NNS	_	_	9	VMOD	_	_
14	,	_	,	_	_	9	P	_	_
15	two	_	CD	_	_	17	NMOD	_	_
16	CD8-	_	JJ	_	_	17	NMOD	_	_
17	ALCL	_	NN	_	_	18	VMOD	_	_
18	expressed	_	VBD	_	_	9	COORD	_	_
19	TIA1	_	NN	_	_	18	VMOD	_	_
20	;	_	:	_	_	18	P	_	_
21	other	_	JJ	_	_	29	NMOD	_	_
22	postthymic	_	JJ	_	_	23	NMOD	_	_
23	T-cell	_	NN	_	_	29	NMOD	_	_
24	,	_	,	_	_	23	P	_	_
25	T-lymphoblastic	_	NN	_	_	23	COORD	_	_
26	,	_	,	_	_	25	P	_	_
27	and	_	CC	_	_	25	COORD	_	_
28	B-cell	_	NN	_	_	27	CONJ	_	_
29	lymphomas	_	NNS	_	_	30	VMOD	_	_
30	were	_	VBD	_	_	18	COORD	_	_
31	consistently	_	RB	_	_	32	AMOD	_	_
32	negative	_	JJ	_	_	30	VMOD	_	_
33	.	_	.	_	_	9	P	_	_
		
1	There	_	EX	_	_	2	VMOD	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	strong	_	JJ	_	_	4	NMOD	_	_
4	correlation	_	NN	_	_	2	VMOD	_	_
5	between	_	IN	_	_	4	NMOD	_	_
6	percentage	_	NN	_	_	8	NMOD	_	_
7	perforin-positive	_	JJ	_	_	8	NMOD	_	_
8	cells	_	NNS	_	_	5	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	zonal	_	JJ	_	_	13	NMOD	_	_
11	tumor	_	NN	_	_	13	NMOD	_	_
12	cell	_	NN	_	_	13	NMOD	_	_
13	death	_	NN	_	_	9	CONJ	_	_
14	.	_	.	_	_	2	P	_	_
		
1	Angioinvasion	_	NN	_	_	6	VMOD	_	_
2	,	_	,	_	_	6	P	_	_
3	in	_	IN	_	_	6	VMOD	_	_
4	contrast	_	NN	_	_	3	PMOD	_	_
5	,	_	,	_	_	6	P	_	_
6	was	_	VBD	_	_	0	ROOT	_	_
7	present	_	JJ	_	_	6	VMOD	_	_
8	only	_	RB	_	_	9	PMOD	_	_
9	in	_	IN	_	_	7	AMOD	_	_
10	a	_	DT	_	_	11	NMOD	_	_
11	proportion	_	NN	_	_	9	PMOD	_	_
12	(	_	(	_	_	14	P	_	_
13	37	_	CD	_	_	14	NMOD	_	_
14	%	_	NN	_	_	11	PRN	_	_
15	)	_	)	_	_	14	P	_	_
16	of	_	IN	_	_	11	NMOD	_	_
17	these	_	DT	_	_	18	NMOD	_	_
18	lymphomas	_	NNS	_	_	16	PMOD	_	_
19	despite	_	IN	_	_	6	VMOD	_	_
20	the	_	DT	_	_	22	NMOD	_	_
21	frequent	_	JJ	_	_	22	NMOD	_	_
22	presence	_	NN	_	_	19	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	zonal	_	JJ	_	_	27	NMOD	_	_
25	tumor	_	NN	_	_	27	NMOD	_	_
26	cell	_	NN	_	_	27	NMOD	_	_
27	death	_	NN	_	_	23	PMOD	_	_
28	(	_	(	_	_	30	P	_	_
29	71	_	CD	_	_	30	NMOD	_	_
30	%	_	NN	_	_	6	PRN	_	_
31	)	_	)	_	_	30	P	_	_
32	.	_	.	_	_	6	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	propose	_	VBP	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	cytolytic	_	JJ	_	_	8	NMOD	_	_
5	effector	_	NN	_	_	8	COORD	_	_
6	and	_	CC	_	_	8	COORD	_	_
7	related	_	JJ	_	_	8	COORD	_	_
8	proteins	_	NNS	_	_	28	VMOD	_	_
9	produced	_	VBN	_	_	8	APPO	_	_
10	by	_	IN	_	_	9	VMOD	_	_
11	putative	_	JJ	_	_	12	NMOD	_	_
12	NK	_	NN	_	_	10	PMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	some	_	DT	_	_	19	NMOD	_	_
15	CD8+	_	JJ	_	_	16	AMOD	_	_
16	CD56+	_	JJ	_	_	19	NMOD	_	_
17	postthymic	_	JJ	_	_	19	NMOD	_	_
18	T-cell	_	NN	_	_	19	NMOD	_	_
19	lymphomas	_	NNS	_	_	13	CONJ	_	_
20	,	_	,	_	_	28	P	_	_
21	probably	_	RB	_	_	22	PMOD	_	_
22	in	_	IN	_	_	28	VMOD	_	_
23	conjunction	_	NN	_	_	22	PMOD	_	_
24	with	_	IN	_	_	23	NMOD	_	_
25	other	_	JJ	_	_	26	NMOD	_	_
26	mechanisms	_	NNS	_	_	24	PMOD	_	_
27	,	_	,	_	_	28	P	_	_
28	may	_	MD	_	_	3	SUB	_	_
29	effect	_	VB	_	_	28	VC	_	_
30	massive	_	JJ	_	_	33	NMOD	_	_
31	tumor	_	NN	_	_	33	NMOD	_	_
32	cell	_	NN	_	_	33	NMOD	_	_
33	apoptosis	_	NN	_	_	29	VMOD	_	_
34	.	_	.	_	_	2	P	_	_
		
1	The	_	DT	_	_	3	NMOD	_	_
2	frequent	_	JJ	_	_	3	NMOD	_	_
3	expression	_	NN	_	_	17	VMOD	_	_
4	of	_	IN	_	_	3	NMOD	_	_
5	cytolytic	_	JJ	_	_	7	NMOD	_	_
6	effector	_	NN	_	_	7	NMOD	_	_
7	markers	_	NNS	_	_	4	PMOD	_	_
8	in	_	IN	_	_	3	NMOD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	CD2+	_	NN	_	_	12	NMOD	_	_
11	surface	_	NN	_	_	12	NMOD	_	_
12	CD3-	_	NN	_	_	8	PMOD	_	_
13	CD56+	_	JJ	_	_	16	NMOD	_	_
14	putative	_	JJ	_	_	16	NMOD	_	_
15	NK-cell	_	NN	_	_	16	NMOD	_	_
16	lymphomas	_	NNS	_	_	12	NMOD	_	_
17	lends	_	VBZ	_	_	0	ROOT	_	_
18	further	_	JJ	_	_	19	NMOD	_	_
19	support	_	NN	_	_	17	VMOD	_	_
20	to	_	TO	_	_	17	VMOD	_	_
21	their	_	PRP$	_	_	25	NMOD	_	_
22	probable	_	JJ	_	_	25	NMOD	_	_
23	NK	_	NN	_	_	25	NMOD	_	_
24	cell	_	NN	_	_	25	NMOD	_	_
25	origin	_	NN	_	_	20	PMOD	_	_
26	.	_	.	_	_	17	P	_	_
		
